If you liked this article you might like

Biotech ETFs May Be a Prescription for Investment Success, Especially if Trump Becomes President
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
Allergan's Vitae Buy Could Spark More Interest in Kadmon
5 Healthy Pharma and Biotech Plays